Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P5
Near historical low
vs 3Y Ago
-12.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -230.08% |
| Q3 2025 | 297.08% |
| Q2 2025 | 70.36% |
| Q1 2025 | 29.74% |
| Q4 2024 | -8.17% |
| Q3 2024 | 16.26% |
| Q2 2024 | 51.84% |
| Q1 2024 | -68.08% |
| Q4 2023 | 10.53% |
| Q3 2023 | 10.93% |
| Q2 2023 | -29.47% |
| Q1 2023 | -20.10% |
| Q4 2022 | 19.07% |
| Q3 2022 | -26.21% |
| Q2 2022 | -14.73% |
| Q1 2022 | -20.89% |
| Q4 2021 | -48.81% |
| Q3 2021 | 10.21% |
| Q2 2021 | 25.73% |
| Q1 2021 | 59.89% |
| Q4 2020 | -509.99% |
| Q3 2020 | 15.91% |
| Q2 2020 | -53.39% |
| Q1 2020 | 20.43% |
| Q4 2019 | 45.01% |
| Q3 2019 | 5.73% |
| Q2 2019 | 4.44% |
| Q1 2019 | -666.86% |
| Q4 2018 | 85.99% |
| Q3 2018 | -65.04% |
| Q2 2018 | -20.37% |
| Q1 2018 | -18.02% |
| Q4 2017 | -43.07% |
| Q3 2017 | 21.99% |
| Q2 2017 | 5.62% |
| Q1 2017 | 20.93% |
| Q4 2016 | 10.55% |
| Q3 2016 | -79.03% |
| Q2 2016 | -38.08% |
| Q1 2016 | 45.80% |